178 related articles for article (PubMed ID: 28222430)
1. MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.
Li P; Yang X; Cheng Y; Zhang X; Yang C; Deng X; Li P; Tao J; Yang H; Wei J; Tang J; Yuan W; Lu Q; Xu X; Gu M
Cell Physiol Biochem; 2017; 41(3):921-932. PubMed ID: 28222430
[TBL] [Abstract][Full Text] [Related]
2. A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.
Han X; Zhen S; Ye Z; Lu J; Wang L; Li P; Li J; Zheng X; Li H; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2017; 41(3):973-986. PubMed ID: 28222434
[TBL] [Abstract][Full Text] [Related]
3. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
4. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway.
Chen Q; Qin R; Fang Y; Li H
Cell Physiol Biochem; 2015; 36(3):956-65. PubMed ID: 26087719
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
Wang YD; Li SJ; Liao JX
Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
[TBL] [Abstract][Full Text] [Related]
6. Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.
Zhi Y; Pan J; Shen W; He P; Zheng J; Zhou X; Lu G; Chen Z; Zhou Z
Cell Physiol Biochem; 2016; 39(5):1787-1794. PubMed ID: 27744452
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
10. miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.
Zeng LP; Hu ZM; Li K; Xia K
J Cell Mol Med; 2016 Mar; 20(3):559-67. PubMed ID: 26800397
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
[TBL] [Abstract][Full Text] [Related]
12. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer.
Nordentoft I; Birkenkamp-Demtroder K; Agerbæk M; Theodorescu D; Ostenfeld MS; Hartmann A; Borre M; Ørntoft TF; Dyrskjøt L
BMC Med Genomics; 2012 Sep; 5():40. PubMed ID: 22954303
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.
Zhou X; Su J; Zhu L; Zhang G
Helicobacter; 2014 Jun; 19(3):174-81. PubMed ID: 24628843
[TBL] [Abstract][Full Text] [Related]
14. Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
Li R; Zheng JZ; Huang X
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9303-9314. PubMed ID: 33015771
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling.
Chen X; Jia C; Jia C; Jin X; Gu X
Cell Physiol Biochem; 2018; 48(2):815-826. PubMed ID: 30032142
[TBL] [Abstract][Full Text] [Related]
16. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
[TBL] [Abstract][Full Text] [Related]
18. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
Yi D; Xu L; Wang R; Lu X; Sang J
Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis.
Zhang ZJ; Zhang YH; Qin XJ; Wang YX; Fu J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2387-2400. PubMed ID: 32196590
[TBL] [Abstract][Full Text] [Related]
20. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
Li X; Han X; Yang J; Sun J; Wei P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
